Filing Flows › Prestige Consumer Healthcare (PBH) › Q2 FY27 › vs Q1 FY27
Prestige Consumer Healthcare (PBH) Q2 FY27 vs Q1 FY27 (quarter over quarter)
Prestige Consumer Healthcare's revenue rose $70.6M (+27%) from $266M in Q1 FY27 to $336M in Q2 FY27. The biggest changes: Wellness, Sleep & Other +$33.0M (+230%); Cough, Cold & Allergy +$15.0M (+70%); Dermatologicals +$10.7M (+32%). Gross margin 51.3% against 51.3% (+0.0 pts).
Prestige Consumer Healthcare, Q2 FY27: revenue $336M (+23% year over year), operating margin 24.0%, net earnings $25.3M, operating cash flow $37.9M. The chart draws each line against Q1 FY27, the increases inside each band.
Margins
| Q2 FY27 | Q1 FY27 | Change | |
|---|---|---|---|
| Gross margin | 51.3% | 51.3% | +0.0 pts |
| Operating margin | 24.0% | 19.8% | +4.2 pts |
| Net margin | 7.5% | 11.0% | -3.5 pts |
| Free cash flow margin | 10.2% | 25.2% | -15.1 pts |
Every line
| Line | Q2 FY27 | Q1 FY27 | Change | % |
|---|---|---|---|---|
| Gastrointestinal | $63.1M | $62.2M | $912K | +1% |
| Women's Health | $53.6M | $52.5M | $1.0M | +2% |
| Wellness, Sleep & Other | $47.3M | $14.3M | $33.0M | +230% |
| Dermatologicals | $43.9M | $33.2M | $10.7M | +32% |
| Cough, Cold & Allergy | $36.3M | $21.3M | $15.0M | +70% |
| Eye & Ear Care | $34.6M | $33.0M | $1.6M | +5% |
| Pain Relief | $30.9M | $26.8M | $4.1M | +15% |
| Oral Care | $26.6M | $22.4M | $4.2M | +19% |
| Revenue | $336M | $266M | $70.6M | +27% |
| Gross profit | $173M | $136M | $36.4M | +27% |
| Cost of revenue | $164M | $130M | $34.2M | +26% |
| Operating profit | $80.7M | $52.5M | $28.2M | +54% |
| Operating expenses | $91.8M | $83.7M | $8.2M | +10% |
| Pre-tax earnings | $47.5M | $38.5M | $8.9M | +23% |
| Other expense, net | $33.3M | $14.0M | $19.3M | +138% |
| Sales & marketing | $52.2M | $34.7M | $17.6M | +51% |
| General & admin | $30.9M | $43.3M | −$12.4M | -29% |
| Other operating costs | $8.7M | $5.7M | $3.0M | +53% |
| Net earnings | $25.3M | $29.2M | −$3.9M | -13% |
| Income tax | $22.2M | $9.4M | $12.8M | +137% |
| Depreciation & amortization | $12.0M | $8.8M | $3.2M | +37% |
| Share-based compensation | $1.2M | $4.0M | −$2.8M | -69% |
| Working capital & other | $625K | −$28.9M | $29.5M | — |
| Operating cash flow | $37.9M | $70.8M | −$32.9M | -47% |
| Free cash flow (OCF − capex) | $34.2M | $67.1M | −$32.8M | -49% |
| Capital expenditures | $3.6M | $3.7M | −$79K | -2% |
Questions
How much did Prestige Consumer Healthcare's revenue grow quarter over quarter in Q2 FY27?
Prestige Consumer Healthcare's revenue rose $70.6M (+27%) from $266M in Q1 FY27 to $336M in Q2 FY27.
What drove Prestige Consumer Healthcare's revenue change in Q2 FY27?
Wellness, Sleep & Other +$33.0M (+230%); Cough, Cold & Allergy +$15.0M (+70%); Dermatologicals +$10.7M (+32%).